You have 9 free searches left this month | for more free features.

City

Daytona Beach (1)

Hangzhou (1)

Shanghai (1)

Xi'an (1)

Condition

Breast Cancer (2)

Metastatic Cancer (2)

Breast Neoplasms (1)

HER2+ Breast Cancer (1)

Healthy (1)

Overall Status

Recruiting (3)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (3)

phase 1 (1)

phase 3 (1)

Sponsor

Fudan University (2)

Eli Lilly and Company (1)

First Affiliated Hospital Xi'an Jiaotong University (1)

Zhejiang Cancer Hospital (1)

Collaborator

Pfizer (1)

Study Documents

Intervention Type

drug (5)

device (1)

Funder Type

Other (4)

Industry (1)

Study Type

Interventional (5)

ai

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Tumors Trial in Hangzhou (Palbociclib, AI)

Recruiting

Breast Neoplasms

Palbociclib
AI

Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital

Jul 13, 2021

Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)

Recruiting

Breast Cancer
Metastatic Cancer

SHR7390
+14 more

Shanghai, Shanghai, China

Cancer Hospital Affiliated to Fudan University

Jul 22, 2022

Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)

Not yet recruiting

Breast Cancer
Metastatic Cancer

SHR-1316
+4 more

(no location specified)

Jan 11, 2022

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting

HER2+ Breast Cancer

Trastuzumab
+9 more

Xi'an, Shaanxi, China
+1 more

Jun 20, 2022

Healthy Trial in Daytona Beach (LY3074828, PFS, AI)

Completed

Healthy

LY3074828
+2 more

Daytona Beach, Florida

Covance Clinical Research Inc

Nov 7, 2019